Cytochrome P-450

Clinical trials for Cytochrome P-450 explained in plain language.

Never miss a new study

Get alerted when new Cytochrome P-450 trials appear

Sign up with your email to follow new studies for Cytochrome P-450, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet finished but already full! 1

Could a targeted drug delay prostate cancer progression?

Disease control Ongoing

This phase 3 trial tests whether adding the targeted drug abemaciclib to standard hormone therapy (abiraterone plus prednisone) can delay cancer growth in men with high-risk prostate cancer that has spread to bones or organs. Participants receive either abemaciclib or a placebo a…

Matched conditions: CYTOCHROME P-450

Phase 3 • Sponsor: Eli Lilly and Company • Aim: Disease control

Last updated Jul 03, 2026 00:00 UTC

Cytochrome P-450

Get alerted when new Cytochrome P-450 trials appear

Could a targeted drug delay prostate cancer progression?